Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine.
about
Emerging analgesics in cancer pain management.Economic evaluation in chronic pain: a systematic review and de novo flexible economic model.The cost of opioid-related adverse drug events.Addressing the barriers related with opioid therapy for management of chronic pain in India.A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain.
P2860
Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Costs of opioid therapy for ch ...... h controlled-release morphine.
@en
Costs of opioid therapy for ch ...... comparing transdermal fentanyl
@nl
type
label
Costs of opioid therapy for ch ...... h controlled-release morphine.
@en
Costs of opioid therapy for ch ...... comparing transdermal fentanyl
@nl
prefLabel
Costs of opioid therapy for ch ...... h controlled-release morphine.
@en
Costs of opioid therapy for ch ...... comparing transdermal fentanyl
@nl
P2093
P2860
P921
P1476
Costs of opioid therapy for ch ...... h controlled-release morphine.
@en
P2093
D Neighbors
H-H Gockel
Lukas Radbruch
P2860
P2888
P304
P356
10.1007/S10198-002-0097-6
P577
2002-06-01T00:00:00Z